News/Drug and Alcohol Dependence 37 (1995) 177-180 119

Pharmacology, Emory University; Representative Publication: Howell, L.L., Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys. J. Phar- macol. Exp. Ther. 266894-903, 1993.

Joyce M. Johnson (Spon: J.H. Jaffe, B.J. Primm), Education: D.O. (1980), Michigan State University; Board Certified in Psychiatry; Current Position: Director, Division of National Treatment Demon- strations, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Admin- istration (SAMHSA); Representative Publication: Johnson, J.M. and Barash, D., A regulatory update on postmarketing drug safety surveillance. Drug Inform. J. 28505-512, 1994.

Marc J. Kaufman (Spon: B.K. Madras, J.H. Mendelson), Education: Ph.D. (1989 - Environmen- tal Health Sciences), Johns Hopkins University; Cur- rent Position: Research Fellow, Department of Psychiatry, Harvard Medical School; Representative Publication: Kaufman, M.J. and Madras, B.K., Dis- tribution of cocaine recognition sites in monkey brain: II. Ex vivo autoradiography with t3H]CFT and [ 1251]RTI-55. Synapse 12:99- 111, 1992.

Alan I. Leshner (Spon: M.W. Adler, M.J. Kreek), Education: Ph.D. (1969 - Physiological Psychol- ogy), Rutgers University; Current Position: Director, National Institute on Drug Abuse; Representative Publication: Leshner, A.I., Evolving views of mental disorders and their treatment. Arch. Family Med. 2:787-790, 1993.

Philip A. May (Spon: R.L. Balster, L.S. Harris), Educa- tion: Ph.D. (1976 - Sociology), University of Mon- tana; Current Position: Director, Center on Alcoholism, Substance Abuse and Addictions and Professor, Department of Sociology, University of New Mexico; Representative Publication: May, P.A., The epidemiology of alcohol abuse among American Indians: The mythical and real properties. J. Am. Ind. Cult. 18:121-143, 1994.

David h4. Novick (Spon: M.J. Kreek, E.M. Unterwald), Education: M.D. (1974), Downstate Medical Center; Board Certified in Internal Medicine and Gastroenterology; Current Position: Associate Clini- cal Professor of Medicine, Wright State University School of Medicine, and Guest Investigator, The Rockefeller University; Representative Publication: Novick, D.M., Richman, B.L., Friedman, J.M., Friedman, J.E., Fried, C., Wilson, J.P., Townley, A. and Kreek, M.J., The medical status of methadone maintenance patients in treatment for 11-18 years. Drug Alcohol Depend. 33:235-245, 1993.

Jerome J. Platt (Spon: J.H. Jaffe, H.D. Kleber), Educa- tion: Ph.D. (1967 - Psychology), University of Georgia; Current Position: Professor, Department of

Psychiatry, and Director, Division of Addiction Re- search and Treatment, Medical College of Penn- sylvania and the Hahnemann University School of Medicine; Representative Publication: Platt, J.J. and Husband, S.D., An overview of problem-solving and social skills approaches in substance abuse treatment. Psychotherapy 30:276-283, 1993.

Charles W. Schindler (Spon: C.E. Johanson, C.R. Schuster), Education: Ph.D. (1980 - Experimental Psychology), The American University; Current Posi- tion: Research Psychologist, NIDA Addiction Re- search Center, and Research Assistant Professor,

* Department of Pharmacology and Therapeutics, University of Maryland; Representative Publication: Schindler, C.W., Goldberg, S.R. and Katz, J.L., Pharmacological specificity of enhanced sensitivity to naltrexone in rats. Psychopharmacology 110:60-68, 1993,a

Larry Stein (Spon: J.V. Brady, C.R. Schuster), Educa- tion: Ph.D. (1955 - Psychology), University of Iowa; Current Position: Professor and Chairman, Depart- ment of Pharmacology, University of California, Ir- vine; Representative Publication: Self, D.W. and Stein, L., Pertussis toxin attenuates intracranial mor- phine self-administration. Pharmacol. Biochem. Behav. 46:689-695, 1993.

Jason h4. White (Spon: G.E. Bigelow, R.R. Griftiths), Education: Ph.D. (1980 - Psychology), University of Adelaide; Current Position: Senior Lecturer and Coordinator, Drug and Alcohol Education, Faculty of Medicine, University of Adelaide; Representative Publication: White, J.M., Dyer, K.R., Ali, R.L., Gaughwin, M.D. and Cormack, S., Injecting behav- iour and risky needle use amongst methadone main- tenance clients. Drug Alcohol Depend. 34: 113- 119, 1994.

ASSOCIATE MEMBERS

Elizabeth J. Cline (Spon: R.L. Balster, L.H. Gold), Education: Ph.D. (1990 - Experitnental Psychol- ogy), University of Wyoming; Current Position: Regular Fellow, Department of Pharmacology, Uni- versity of Colorado; Representative Publication: Cline, E.J., Scheffel, U., Boja, J.W., Carrol, F.I., Katz, J.L. and Kuhar, M.J., Behavioral effects of novel cocaine analogs: A comparison with in vivo receptor binding potency. J. Pharmacol. Exp. Ther. 260:1174-1179, 1992.

Charles J. Heyser (Spon: L.H. Gold, L.P. Spear), Education: Ph.D. (1993 - Psychobiology), SUNY at Binghamton; Current Position: Postdoctoral Re-

180 News/Drug and Alcohol Dependence 37 (1995) 177-180

search Associate, Department of Neurophar- macology, The Scripps Research Institute; Representative Publication: Molina, V.A., Heyser, C.J. and Spear, L.P., Chronic variable stress enhances the stimulatory action of a low dose of mor- phine: Reversal by desipramine. Eur. J. Pharmacol. 260:57-64, 1994.

David A. Wasserman (Spon: S.M. Hall, J.L. Sorensen), Education: Ph.D. (1987 - Clinical Psychology), Uni- versity of Oregon; Current Position: Assistant Ad- junct Professor, Department of Psychiatry, University of California, San Francisco, and V.A. Medical Center; Representative Publication: Havassy, B.E., Hall, S.M. and Wasserman, D.A., Social support and relapse: Commonalities among alcoholics, opiate users, and cigarette smokers. Addict. Behav. 16:235-246, 1991.

REPORT OF THE CPDD HUMAN RESEARCH COMMITI’EE

The purpose of the Human Research Committee (HRC) is to foster and support human research on drug abuse. Members of the committee include Leslie Amass, Kathleen Brady, Roland Griffith, Tom Kosten, Roy Pickens (Chair), John Roache, Maxine Stitzer, Harriet de Wit, and Ed Sellers (ex officio). Griffith, Kosten, Pickens, Stitzer, and Sellers are CPDD Board members, and Amass, Brady, Roche, and de Wit are CPDD regu- lar members.

Recently the HRC prepared a report for the CPDD Board of Directors on human subject issues in research involving the administration of drugs with abuse poten- tial to human subjects. The report noted that this methodology is sometimes employed in research to learn more about the causes and consequences of drug abuse and to develop new treatments for drug dependence. The methodology is also employed in research outside the drug abuse field, including efforts to better unders- tand basic mechanisms in pain, sleep, appetite, intestinal functioning, anxiety, depression, and other problem areas. The report discusses human subject issues that are relevant to this type of research (e.g., obtaining in- formed consent, minimizing risks, assessing risk-benefit ratio, compensation) and describes safeguards that have been established to protect human subjects who serve in these studies.

At the forthcoming CPDD meeting in Scottsdale, the HRC will hold a special session to discuss issues relevant to the implementation of the new NIH guidelines on in- clusion of women and minorities as subjects in clinical research. All interested persons are invited to attend and participate. Date, time, and location of the session will be announced at the CPDD meeting. Comments are welcomed from CPDD members on other clinical research issues the HRC may address.

Prepared by Roy W. Pickens, Ph.D., Committee Chair